Abigail Lishman

Abigail Lishman is Head of Commercial Development at Dxcover Limited, where she is responsible for building uptake and adoption of Dxcover’s innovative liquid biopsy technology with providers in the UK NHS and private system, and the EU. This role involves working in partnership with healthcare professionals, healthcare systems, innovation teams, and patient advocacy groups.

Abi has held a range of industry roles and leadership positions throughout her few decades in life sciences, including medical publishing at Reed Elsevier; medical technology sales directly into NHS and private hospitals, and leadership of teams doing the same at a European level; and real-world health economics and outcomes research involving design, set up and execution of observational studies for primary data collection, and use of routinely collected data, to generate data for health economic and clinical value cases across pharmaceuticals, diagnostics, and devices.

Abi is motivated by the opportunity to truly make a difference. She is passionate about innovation and technologies that have the capacity to change the paradigm, meet unmet need, and bring improvements in outcomes for patients, healthcare providers, and healthcare systems.